BRADLEY FOSTER & SARGENT INC/CT - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 90 filers reported holding CYTOSORBENTS CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BRADLEY FOSTER & SARGENT INC/CT ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q3 2023$35,9000.0%10,0000.0%0.00%0.0%
Q2 2023$35,900
+6.5%
10,0000.0%0.00%0.0%
Q1 2023$33,700
+81.2%
10,000
-16.7%
0.00%
Q4 2022$18,600
+32.9%
12,000
+20.0%
0.00%
Q3 2022$14,000
-36.4%
10,0000.0%0.00%
-100.0%
Q2 2022$22,000
-31.2%
10,0000.0%0.00%0.0%
Q1 2022$32,000
-25.6%
10,000
-2.4%
0.00%0.0%
Q4 2021$43,000
-84.5%
10,250
-70.1%
0.00%
-85.7%
Q3 2021$278,000
-9.7%
34,240
-16.0%
0.01%0.0%
Q2 2021$308,000
-11.0%
40,740
+2.2%
0.01%
-22.2%
Q1 2021$346,000
+10.9%
39,876
+1.9%
0.01%
+12.5%
Q4 2020$312,0000.0%39,1400.0%0.01%
-11.1%
Q3 2020$312,000
+22.8%
39,140
+19.0%
0.01%
-10.0%
Q1 2020$254,000
+98.4%
32,890
-0.9%
0.01%
+150.0%
Q4 2019$128,000
-44.1%
33,189
-27.1%
0.00%
-50.0%
Q3 2019$229,000
-70.8%
45,497
-61.7%
0.01%
-69.2%
Q2 2019$785,000
-21.4%
118,751
-10.0%
0.03%
-25.7%
Q1 2019$999,000
-17.6%
132,012
-12.0%
0.04%
-28.6%
Q4 2018$1,212,000
-35.0%
149,978
+3.8%
0.05%
-22.2%
Q3 2018$1,864,000
+17.2%
144,492
+3.5%
0.06%
+10.5%
Q2 2018$1,591,000139,5660.06%
Other shareholders
CYTOSORBENTS CORP shareholders Q1 2022
NameSharesValueWeighting ↓
CM Management, LLC 450,000$846,0000.90%
Skylands Capital, LLC 2,944,670$5,535,9800.84%
Sargent Investment Group, LLC 1,257,048$2,363,2500.57%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 197,940$372,1270.52%
Avenir Corp 2,717,397$5,108,7060.48%
Granahan Investment Management 1,552,393$2,918,4990.10%
Seelaus Asset Management LLC 20,450$38,4460.04%
HighMark Wealth Management LLC 10,000$18,8000.02%
Key Client Fiduciary Advisors, LLC 13,000$24,4400.02%
Eudaimonia Partners, LLC 23,500$44,1800.01%
View complete list of CYTOSORBENTS CORP shareholders